ARCHIMED, an investment firm, completed the acquisition of Instem, an information solution and scientific insight services provider, for £203m. “I’m truly excited about this next chapter in our transformational growth story and one that keeps our clients at the center. Instem has never been healthier, and the future has never been brighter for our client community and staff. By strategically partnering with ARCHIMED, it will empower us to accelerate our growth initiatives, expand our market presence, and pursue new opportunities that will drive our company to new heights," Phil Reason, Instem CEO.